Aditxt, Inc. Increase (Decrease) in Deposits Outstanding
Aditxt, Inc. (ADTX) reported Increase (Decrease) in Deposits Outstanding of $26.09 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositsOutstanding · last filed 2024-05-20
- Aditxt, Inc. increase (decrease) in deposits outstanding for the quarter ending 2024-03-31 was $26.09K, a 52.52% decline year-over-year.
- Aditxt, Inc. increase (decrease) in deposits outstanding for the quarter ending 2023-12-31 was -$205.85K.
- Aditxt, Inc. increase (decrease) in deposits outstanding for the quarter ending 2023-09-30 was $25.00K, a 95.38% decline year-over-year.
- Aditxt, Inc. increase (decrease) in deposits outstanding for the quarter ending 2023-06-30 was -$123.04K.
- Aditxt, Inc. increase (decrease) in deposits outstanding for fiscal 2023 was -$248.96K.
- Aditxt, Inc. increase (decrease) in deposits outstanding for fiscal 2022 was -$23.88K, a 126.58% decline from fiscal 2021.
- Aditxt, Inc. increase (decrease) in deposits outstanding for fiscal 2021 was $89.84K, a 24.27% increase from fiscal 2020.
- Aditxt, Inc. increase (decrease) in deposits outstanding for fiscal 2020 was $72.30K.
| Period end | Increase (Decrease) in Deposits Outstanding 3 month | Increase (Decrease) in Deposits Outstanding 6 month | Increase (Decrease) in Deposits Outstanding 9 month | Increase (Decrease) in Deposits Outstanding 12 month | Increase (Decrease) in Deposits Outstanding 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $26.09K 10-Q · filed 2024-05-20 | -$179.77K derived: sum of 2 quarters · filed 2024-05-20 | -$154.77K derived: sum of 3 quarters · filed 2024-05-20 | -$277.81K derived: sum of 4 quarters · filed 2024-05-20 | |
| 2023-12-31 | -$205.85K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$180.85K derived: sum of 2 quarters · filed 2024-04-16 | -$303.90K derived: sum of 3 quarters · filed 2024-04-16 | -$248.96K 10-K · filed 2024-04-16 | |
| 2023-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$98.04K derived: sum of 2 quarters · filed 2023-11-14 | -$43.10K 10-Q · filed 2023-11-14 | -$639.95K derived: sum of 4 quarters · filed 2024-05-20 | |
| 2023-06-30 | -$123.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$68.10K 10-Q · filed 2023-08-14 | -$664.95K derived: sum of 3 quarters · filed 2024-05-20 | -$123.57K derived: sum of 4 quarters · filed 2024-05-20 | |
| 2023-03-31 | $54.94K 10-Q · filed 2024-05-20 | -$541.91K derived: sum of 2 quarters · filed 2024-05-20 | -$531.00 derived: sum of 3 quarters · filed 2024-05-20 | -$36.53K derived: sum of 4 quarters · filed 2024-05-20 | |
| 2022-12-31 | -$596.85K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$55.47K derived: sum of 2 quarters · filed 2024-04-16 | -$91.47K derived: sum of 3 quarters · filed 2024-04-16 | -$23.88K 10-K · filed 2024-04-16 | $438.12K 10-K · filed 2023-04-17 |
| 2022-09-30 | $541.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $505.38K derived: sum of 2 quarters · filed 2023-11-14 | $572.97K 10-Q · filed 2023-11-14 | $419.45K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $31.59K 10-Q · filed 2023-08-14 | -$121.93K derived: sum of 3 quarters · filed 2023-08-14 | -$263.28K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $67.59K 10-Q · filed 2023-05-15 | -$85.93K derived: sum of 2 quarters · filed 2023-05-15 | -$227.28K derived: sum of 3 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$153.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$294.86K derived: sum of 2 quarters · filed 2023-04-17 | $89.84K 10-K · filed 2023-04-17 | $306.95K 10-K · filed 2022-03-31 | |
| 2021-09-30 | -$141.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $243.36K 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $384.71K 10-Q · filed 2022-08-15 | ||||
| 2020-12-31 | $10.71K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $72.30K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $61.59K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |